These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 7691497
1. Drug therapy of renovascular hypertension. Rosenthal T. Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497 [Abstract] [Full Text] [Related]
2. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease. Deshmukh H, Barker E, Anbarasan T, Levin D, Bell S, Witham MD, George J. Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589 [Abstract] [Full Text] [Related]
3. Treatment of severe hypertension in a 14-year-old child: Successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension. Zhang X, Xu Y, Chen X, Wang S, Li X, Yan X. Clin Exp Hypertens; 2017 Dec; 39(7):587-591. PubMed ID: 28621587 [Abstract] [Full Text] [Related]
4. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report. Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP. Scand J Urol Nephrol Suppl; 1984 Dec; 79():103-6. PubMed ID: 6089307 [Abstract] [Full Text] [Related]
5. [Hypertension therapy in patients with renal artery stenosis]. Vogt B, Maillard M, Burnier M. Ther Umsch; 2012 May; 69(5):279-81. PubMed ID: 22547359 [Abstract] [Full Text] [Related]
6. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases]. Alhadad A, Sterner G, Herlitz H. Lakartidningen; 2012 May; 106(44):2836-8, 2840. PubMed ID: 19967962 [No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors in hypertension: a review. Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S. Int J Clin Pharmacol Res; 1985 Apr; 5(6):429-38. PubMed ID: 3005182 [Abstract] [Full Text] [Related]
10. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension. Mimran A. J Cardiovasc Pharmacol; 1992 Apr; 19 Suppl 6():S45-50. PubMed ID: 1382165 [Abstract] [Full Text] [Related]
11. [Pharmacological basis of antihypertensive drug therapy]. Kolck UW, Zaugg CE, Erne P. Praxis (Bern 1994); 2004 May 12; 93(20):847-56. PubMed ID: 15195836 [Abstract] [Full Text] [Related]
12. Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists. Picciotto G, Sargiotto A, Petrarulo M, Rabbia C, De Filippi PG, Roccatello D. J Nucl Med; 2003 Oct 12; 44(10):1574-81. PubMed ID: 14530469 [Abstract] [Full Text] [Related]